PRC Clinical adds SimpleCTMS to eClinical services
PRC Clinical will incorporate SimpleCTMS into their suite of eClinical services to carry out a full suite of clinical services while maintaining level of quality standards. PRC Clinical
US-based gene therapy biotech Seawolf Therapeutics and Sanofi have signed a multi-target research partnership and exclusive licensing deal worth up to $1.2bn to develop treatments for bleeding disorders and other undisclosed indications.
The synthetic vasopressin analogue acts through the vasopressin V1 receptor as a systemic vasoconstrictor, primarily in the splanchnic (abdominal) circulation. Thus effective arterial volume increases and renal blood